Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Ascendis Pharma A/S changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 168 | 1 | 183 | +16 |
| Shares | 63.2M | 10 | 66.7M | +3.50M (+5.5%) |
| Value | $5.88B | $1.00K | $6.89B | +$1.02B (+17.3%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Ascendis Pharma A/S at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (21)
Institutions that held Ascendis Pharma A/S at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Assenagon Asset Management S.A. | 276,348 | $25.7M |
| Jump Financial, LLC | 39,938 | $3.71M |
| Allianz Asset Management GmbH | 18,105 | $1.68M |
| Bank of Montreal | 13,190 | $1.23M |
| Arrowstreet Capital, Limited Partnership | 13,105 | $1.22M |
| Graham Capital Management, L.P. | 9,466 | $879.0K |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 6,729 | $626.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,093 | $380.0K |
| Norges Bank | 3,727 | $346.5K |
| OneAscent Financial Services LLC | 3,391 | $315.0K |
| LPL Financial LLC | 2,288 | $213.0K |
| Cutler Group LP | 1,772 | $164.0K |
| Captrust Financial Advisors | 1,594 | $148.0K |
| State of Wyoming | 446 | $41.0K |
| Skandinaviska Enskilda Banken AB (publ) | 193 | $18.0K |
| Chilton Capital Management LLC | 167 | $16.0K |
| Asset Management One Co.,Ltd. | 100 | $9.00K |
| TFC Financial Management | 70 | $7.00K |
| AdvisorNet Financial, Inc | 34 | $3.00K |
| First Horizon Advisors, Inc. | 19 | $2.00K |
| Steward Financial Group LLC | 1 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Ascendis Pharma A/S at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fieldpoint Private Securities, LLC | 10 | $1.00K |